Chlorhexidine & Pneumonia in Nursing Home Residents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00841074
Recruitment Status : Completed
First Posted : February 11, 2009
Last Update Posted : April 14, 2017
National Institute of Dental and Craniofacial Research (NIDCR)
Information provided by (Responsible Party):
Catherine J Binkley, University of Louisville

Brief Summary:
The purpose of this study is determine if topical oral application of a chlorhexidine antimicrobial spray will significantly reduce pneumonia and respiratory infections, and improve oral health compared to a placebo solution in nursing home residents.

Condition or disease Intervention/treatment Phase
Pneumonia Respiratory Infection Drug: chlorhexidine Drug: Placebo mouthwash Phase 1

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 75 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Effect of Topical Oral Chlorhexidine in Reducing Pneumonia in Nursing Home Residents
Study Start Date : January 2006
Actual Primary Completion Date : July 2011
Actual Study Completion Date : July 2011

Arm Intervention/treatment
Experimental: 1
Peridex mouthwash
Drug: chlorhexidine
0.12% chlorhexidine mouthwash spray, ~1.3 ml, twice a day.
Other Name: Peridex

Placebo Comparator: 2
Placebo mouthwash
Drug: Placebo mouthwash
Placebo mouthwash spray application of ~1.3 ml twice a day.
Other Name: Peridex mouthwash without chlorhexidine.

Primary Outcome Measures :
  1. Pneumonia [ Time Frame: 12 months ]

Secondary Outcome Measures :
  1. Respiratory pathogens [ Time Frame: 12 months ]
  2. Plaque and Gingival Indices [ Time Frame: 12 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  1. Participants must be at least 65 years old.
  2. Be dependent in 2 or more Activities of Daily Living as noted on the nursing home resident's Minimum Data Set - One must be ADL J- Personal Hygiene.
  3. Have natural teeth and/or wear complete or partial dentures.
  4. Expected to be a resident in a nursing home for two years.

Exclusion Criteria:

  1. Existing pneumonia.
  2. History of chlorhexidine reaction or allergy and/or multiple medication or substance allergies.
  3. Receiving chlorhexidine oral application at enrollment as prescribed by physician or dentist.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00841074

United States, Kentucky
University of Louisville
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
University of Louisville
National Institute of Dental and Craniofacial Research (NIDCR)
Principal Investigator: Catherine J Binkley, DDS, PhD University of Louisville

Responsible Party: Catherine J Binkley, PI, University of Louisville Identifier: NCT00841074     History of Changes
Other Study ID Numbers: OGMB040944
First Posted: February 11, 2009    Key Record Dates
Last Update Posted: April 14, 2017
Last Verified: December 2016

Keywords provided by Catherine J Binkley, University of Louisville:
Respiratory pathogens

Additional relevant MeSH terms:
Respiratory Tract Infections
Lung Diseases
Respiratory Tract Diseases
Chlorhexidine gluconate
Anti-Infective Agents, Local
Anti-Infective Agents
Dermatologic Agents